Literature DB >> 17949898

Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.

Ming Shi1, Yang Zheng, Avalon Garcia, Lizhong Xu, David A Foster.   

Abstract

Phospholipase D (PLD) is elevated in rodent fibroblasts expressing activated H-Ras mutants. We therefore examined the PLD activity in human cancer cells with activating Ras mutations. T24 bladder carcinoma cells express an activated H-Ras gene and Calu-1 lung carcinoma cells express an activated K-Ras gene. We report here that both of these cancer cell lines express highly elevated levels of PLD activity and that the PLD activity is dependent upon Ras. We also show that the PLD activity is dependent upon the Ras effector molecules RalA and phosphatidylinositol-3-kinase (PI3K). PLD activity has been shown to provide a survival signal in breast cancer cell lines that suppressed stress-induced apoptosis. Suppression of PLD activity in the T24 and Calu-1 cells resulted in apoptotic cell death in the absence of serum, indicating that the elevated PLD activity provided a survival signal in these cancer cell lines. Suppression of Ras, RalA, or PI3K also led to apoptosis in the absence of serum. These data indicate that a critical component of Ras signaling in human cancer cells is the activation of PLD and that targeting PLD survival signals in cancer cells could be an effective strategy to induce apoptosis in human cancers with activating Ras mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949898      PMCID: PMC3618667          DOI: 10.1016/j.canlet.2007.09.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

Review 1.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

2.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

3.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.

Authors:  E Taparowsky; Y Suard; O Fasano; K Shimizu; M Goldfarb; M Wigler
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

Review 4.  Phospholipase D in cell proliferation and cancer.

Authors:  David A Foster; Lizhong Xu
Journal:  Mol Cancer Res       Date:  2003-09       Impact factor: 5.852

5.  Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

Authors:  Li Hui; Tarek Abbas; Rafal M Pielak; Troy Joseph; Jill Bargonetti; David A Foster
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 6.  Targeting mTOR-mediated survival signals in anticancer therapeutic strategies.

Authors:  David A Foster
Journal:  Expert Rev Anticancer Ther       Date:  2004-08       Impact factor: 4.512

7.  Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.

Authors:  William Pao; David S Klimstra; Galen H Fisher; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

8.  Phospholipase D confers rapamycin resistance in human breast cancer cells.

Authors:  Yuhong Chen; Yang Zheng; David A Foster
Journal:  Oncogene       Date:  2003-06-19       Impact factor: 9.867

9.  Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.

Authors:  K Shimizu; D Birnbaum; M A Ruley; O Fasano; Y Suard; L Edlund; E Taparowsky; M Goldfarb; M Wigler
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

10.  Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells.

Authors:  Momoko Yamada; Yoshiko Banno; Yoh Takuwa; Masahiro Koda; Akira Hara; Yoshinori Nozawa
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more
  36 in total

1.  Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.

Authors:  Robert R Lavieri; Sarah A Scott; Paige E Selvy; Kwangho Kim; Satyawan Jadhav; Ryan D Morrison; J Scott Daniels; H Alex Brown; Craig W Lindsley
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

Review 2.  The Rho guanine nucleotide exchange factors Intersectin 1L and β-Pix control calcium-regulated exocytosis in neuroendocrine PC12 cells.

Authors:  F Momboisse; S Ory; M Ceridono; V Calco; N Vitale; M-F Bader; S Gasman
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

Review 3.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

4.  Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

Authors:  David A Foster; Paige Yellen; Limei Xu; Mahesh Saqcena
Journal:  Genes Cancer       Date:  2010-11

Review 5.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

6.  Reciprocal regulation of AMP-activated protein kinase and phospholipase D.

Authors:  Suman Mukhopadhyay; Mahesh Saqcena; Amrita Chatterjee; Avalon Garcia; Maria A Frias; David A Foster
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

7.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

8.  Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine.

Authors:  Elyssa Bernfeld; Deepak Menon; Vishaldeep Vaghela; Ismat Zerin; Promie Faruque; Maria A Frias; David A Foster
Journal:  J Biol Chem       Date:  2018-09-07       Impact factor: 5.157

Review 9.  Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Authors:  David A Foster; Darin Salloum; Deepak Menon; Maria A Frias
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

Review 10.  Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.

Authors:  Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.